SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
EMBC

Embecta Corp. (NASDAQ:EMBC)

US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
6.19-0.14 (-2.21%)
 
Market cap
$351M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 22, 2022
Market Cap350.72M-54.7%
Revenue (ttm)1.02B-7.6%
Net Income87.50M+5.5%
EPS1.48+4.4%
Shares Out56.66M
PE Ratio4.15
Forward PE3.17
Dividend$0.32(5.17%)
Ex-Dividend DateAug 27, 2026
Volume623,118
Open6.11
Previous Close6.33
Day's Range5.78 - 6.38
52-Week Range2.77 - 14.91
Beta0.81
AnalystsHold
Price Target16.67(+169.31%)
Earnings DateNov 24, 2026
Insider Score
77/ 100
EMBC Insider Score
Bullish

4 qualifying trades · 4 insiders · $557.95K bought in the last 90 days

Embecta Corp. Stock Analysis — InsiderScore

See top-rated InsiderScore stocks ›
65th Percentile Overall Score
EMBC InsiderScore:77 / 99

Embecta Corp. scored higher than 65% of companies evaluated by InsiderBuying, and ranked 16th out of 52 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Embecta Corp. bought $557.9K of stock across 4 purchases in the last 90 days, the largest of them $223.8K.

Stake Increase

The average purchase added about 22% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

About EMBC

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

Address
300 Kimball Drive, Parsippany, NJ, 07054, US
Market Cap
351 million
Employees
1,850
Industrial Classification
Medical - Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$36.97K
Bought
$557.95K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Sound
From EMBC’s reported statements · Q2 2026 (trailing 12 months)

Next catalysts

Ask Barron about EMBC

1 Day
-2.21%
5 Days
-1.43%
1 Month
+7.65%
6 Months
+70.05%
1 Year
-54.72%

$EMBC stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of EMBC by members of U.S. Congress

PoliticianTypeTraded
Tom ColeHouse / RPurchase$1.00K – $15.00KApr 1, 2022

Recently reported changes in EMBC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by EMBC's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

EMBC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

EMBC Revenue by Segment or Geography

$316.60MTotal
SegmentRevenue% of All
Customer rebate liability$159.40M50.35%
Rebates recorded$157.20M49.65%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New EMBC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to EMBC from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in EMBC

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$10.37M
IWMiShares Russell 2000 ETF$9.77M
IWNiShares Russell 2000 Value ETF$3.53M
VXFVanguard Extended Market ETF$3.51M
SLYSPDR S&P 600 Small Cap ETF$3.44M
CALFPacer US Small Cap Cash Cows ETF$3.40M

Estimated from each fund’s disclosed top holdings × AUM

EMBC Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

77
Positive
Data completeness: 92%

Bull Case vs Bear Case

AI-generated from EMBC’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

77/ 100
Insider Activity
Open-market Form 4 buying
Strong
Transaction Size
Purchase $ vs. market cap
Strong
Insider Ownership
Stake increase by buyers
Neutral
Buyer Cluster
Multiple insiders buying together
Strong
Track Record
Past insider-buy performance
Strong
Market Timing
Timing vs. recent price trend
Strong

Healthcare: ranks #17 of 53 scored Healthcare stocks · sector average 67.1

What’s Behind the Score

Insider Activity
60% of score
76.56
Analyst Ratings
40% of score
40
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
4
Sells
1
Buy Value
$557.95K
Distinct Buyers
4

Insider Score Trend Over Time

+22.7 since Aug 27
0255075100Aug 27 — Insider Score 61.0Aug 28 — Insider Score 60.0Aug 29 — Insider Score 60.0Aug 30 — Insider Score 60.0Aug 31 — Insider Score 60.0Sep 1 — Insider Score 86.7Sep 2 — Insider Score 87.7Sep 3 — Insider Score 87.3Sep 4 — Insider Score 87.2Sep 5 — Insider Score 86.6Sep 6 — Insider Score 86.6Sep 7 — Insider Score 86.6Sep 8 — Insider Score 86.7Sep 9 — Insider Score 86.5Sep 10 — Insider Score 85.7Sep 11 — Insider Score 85.2Sep 12 — Insider Score 85.3Sep 13 — Insider Score 85.3Sep 14 — Insider Score 84.0Sep 15 — Insider Score 83.6Sep 16 — Insider Score 82.5Sep 17 — Insider Score 81.7Sep 18 — Insider Score 81.4Sep 19 — Insider Score 81.2Sep 20 — Insider Score 81.2Sep 21 — Insider Score 81.2Sep 22 — Insider Score 80.2Sep 23 — Insider Score 79.5Sep 24 — Insider Score 78.5Sep 25 — Insider Score 87.2Sep 26 — Insider Score 87.2Sep 27 — Insider Score 87.2Sep 28 — Insider Score 87.3Sep 29 — Insider Score 86.7Sep 30 — Insider Score 86.4Oct 1 — Insider Score 85.9Oct 2 — Insider Score 55.0Oct 3 — Insider Score 85.5Oct 4 — Insider Score 85.7Oct 5 — Insider Score 85.7Oct 6 — Insider Score 85.5Oct 7 — Insider Score 85.2Oct 8 — Insider Score 85.1Oct 9 — Insider Score 84.8Oct 10 — Insider Score 84.3Oct 11 — Insider Score 84.9Oct 12 — Insider Score 84.9Oct 13 — Insider Score 84.8Oct 14 — Insider Score 84.3Oct 15 — Insider Score 84.2Oct 16 — Insider Score 83.9Oct 17 — Insider Score 83.8Oct 18 — Insider Score 84.0Oct 19 — Insider Score 84.1Oct 20 — Insider Score 83.9Oct 21 — Insider Score 83.9Oct 22 — Insider Score 84.0Oct 23 — Insider Score 83.8Oct 24 — Insider Score 83.8Oct 25 — Insider Score 83.7Aug 27Sep 25Oct 25

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.